+Search query
-Structure paper
| Title | Structural design of the anti-TNF alpha therapeutic NANOBODY® compound, ozoralizumab, to support its potent and sustained clinical efficacy. |
|---|---|
| Journal, issue, pages | Biochem. Biophys. Res. Commun., Vol. 734, Page 150454-150454, Year 2024 |
| Publish date | Apr 22, 2024 (structure data deposition date) |
Authors | Mima, M. / Mishima-Tsumagari, C. / Nakano, K. / Morimoto, M. / Ogata, H. / Sakata, M. / Iwaoka, R. / Iwata, K. / Hachiuma, K. / Iwamoto, K. ...Mima, M. / Mishima-Tsumagari, C. / Nakano, K. / Morimoto, M. / Ogata, H. / Sakata, M. / Iwaoka, R. / Iwata, K. / Hachiuma, K. / Iwamoto, K. / Fujii, Y. / Kurokawa, T. |
External links | Biochem. Biophys. Res. Commun. / PubMed:39083975 |
| Methods | X-ray diffraction |
| Resolution | 2.05 - 2.59 Å |
| Structure data | ![]() PDB-8z8m: ![]() PDB-8z8v: |
| Chemicals | ![]() ChemComp-HOH: |
| Source |
|
Keywords | CYTOKINE / TNF / VHH / Ozoralizumab / TRANSPORT PROTEIN / HSA |
Movie
Controller
Structure viewers
About Yorodumi Papers



Authors
External links


homo sapiens (human)
Keywords